Aspartate aminotransferase-To-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men

Jennifer C. Price, Eric C. Seaberg, Valentina Stosor, Mallory D. Witt, Carling D. Lellock, Chloe L. Thio

Research output: Contribution to journalArticlepeer-review

Abstract

The utility of longitudinal AST-To-platelet ratio index (APRI), a surrogate for hepatic fibrosis, is unknown.We compared APRI up to 9 years before liver-related death among 57 cases of viral hepatitis-infected men (91% HIVR) to matched controls. APRI was stable among controls but, among cases, increased 4.6%/year from 9 to 3 years predeath (PU0.10) and 30%/year during the 3 years predeath (P0.001). Thus, rapid APRI increase may predict impending liver-related death in HIV-viral hepatitis coinfection.

Original languageEnglish (US)
Pages (from-to)2636-2638
Number of pages3
JournalAIDS
Volume32
Issue number17
DOIs
StatePublished - 2018

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Aspartate aminotransferase-To-platelet ratio index increases significantly 3 years prior to liver-related death in HIV-hepatitis-coinfected men'. Together they form a unique fingerprint.

Cite this